Behavioral
Compassion Pediatrics LLC
Compassion Pediatrics LLC was paid $8.03M by Medicaid between Jan 2019 and Dec 2024, across 81 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoCOMPASSION PEDIATRICS LLC
ORLANDO, FL 32822
ORLANDO, FL 32822
33aNPI1194066761assigned 03/07/2013
33bProvider typeProfessional Counselor
28Total paid$8.03M
24GClaims228,462
24DCodes billed81
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Professional Counselor providers in Florida
Rank by total paid#1 of 31
Median peer was paid$43K
This provider vs. median187×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 26,326 | $620K | |
| 2020 | 28,687 | $936K | |
| 2021 | 46,600 | $1.55M | |
| 2022 | 62,515 | $2.59M | |
| 2023 | 42,223 | $1.61M | |
| 2024incomplete | 22,111 | $723K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 29,282 | 25,705 | $1.90M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 15,832 | 14,111 | $1.21M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 9.2% | 3,966 | 772 | $740K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.0% | 6,425 | 6,197 | $727K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.6% | 5,594 | 5,079 | $611K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 4,623 | 4,455 | $494K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.8% | 14,551 | 13,861 | $303K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 2,524 | 2,426 | $277K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.1% | 9,242 | 8,867 | $245K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 3.0% | 1,151 | 1,068 | $239K |
| 90461 | 1.9% | 7,692 | 7,090 | $154K | |
| 99401 | 1.4% | 9,426 | 8,855 | $116K |
69 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 5,107 | $107K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.3% | 979 | $101K |
| 90670 | 1.2% | 3,550 | $100K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 1,266 | $99K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,417 | $79K |
| 99381 | <1% | 853 | $73K | |
| 99406 | <1% | 9,044 | $66K | |
| 90698 | <1% | 3,902 | $39K | |
| 99383 | <1% | 287 | $33K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,174 | $28K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 440 | $25K |
| 99384 | <1% | 175 | $24K | |
| 99188 | <1% | 2,395 | $24K | |
| 90680 | <1% | 2,673 | $18K | |
| 85018 | <1% | 13,026 | $18K | |
| 99382 | <1% | 139 | $16K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 394 | $16K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 843 | $12K |
| 99205 | Prolong outpt/office vis | <1% | 92 | $10K |
| 90716 | <1% | 787 | $10K | |
| 83655 | <1% | 1,784 | $10K | |
| T2023 | Targeted case management; per month | <1% | 46 | $9K |
| 90710 | <1% | 624 | $8K | |
| 81002 | <1% | 5,391 | $8K | |
| 97802 | <1% | 1,612 | $7K | |
| 90651 | <1% | 1,368 | $7K | |
| 87807 | <1% | 811 | $7K | |
| 90744 | <1% | 2,275 | $6K | |
| 90707 | <1% | 743 | $6K | |
| 92551 | <1% | 11,928 | $5K | |
| 90633 | <1% | 2,555 | $5K | |
| 99173 | <1% | 11,216 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 580 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,536 | $4K |
| 96127 | <1% | 2,551 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 118 | $2K |
| 0071A | <1% | 116 | $2K | |
| 90686 | <1% | 1,465 | $2K | |
| 90700 | <1% | 272 | $1K | |
| 0072A | <1% | 91 | $1K | |
| 90671 | <1% | 416 | $1K | |
| 90620 | <1% | 291 | $1K | |
| 90677 | <1% | 165 | $1K | |
| 69210 | <1% | 173 | $981.50 | |
| 90734 | <1% | 493 | $829.89 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $796.45 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 130 | $747.06 |
| 99051 | <1% | 89 | $586.82 | |
| 99402 | <1% | 50 | $433.81 | |
| 90713 | <1% | 26 | $429.44 | |
| 81001 | <1% | 44 | $415.08 | |
| 96161 | <1% | 414 | $410.87 | |
| 90696 | <1% | 618 | $364.23 | |
| 36416 | <1% | 10,571 | $296.74 | |
| 0002A | <1% | 12 | $270.00 | |
| 0001A | <1% | 12 | $266.00 | |
| 90715 | <1% | 428 | $261.49 | |
| 90648 | <1% | 53 | $235.89 | |
| 90619 | <1% | 245 | $210.00 | |
| 90621 | <1% | 27 | $201.81 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 424 | $136.33 |
| 90688 | <1% | 306 | $120.27 | |
| 99408 | <1% | 76 | $115.71 | |
| 99072 | <1% | 79 | $2.90 | |
| 91307 | <1% | 207 | $0.23 | |
| 91300 | <1% | 38 | $0.01 | |
| 99404 | 0% | 61 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 30 | $0.00 |
| 3008F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOW, LESLEY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Compassion Services | Pikeville, KY | $3.30M |
| Compassion Pediatrics of Wayland | Wayland, KY | $366K |
| Compassion Pediatric Urgent Care LLC | Orlando, FL | $117K |
| Sebree Medical Group | Sebree, KY | $37K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.